You might assume multi organ protection impacted the trial design - but there's nothing on clinicaltrials.gov to suggest this.
The reality; it's been a failing of every iteration of RAC in managing expectations and delivering against guidance. Another few weeks and we'll be sitting at 12 month lows... More opportunity cost for poor ol' RAC holders.
RAC Price at posting:
$1.16 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)